What does the DHR and NBT CGD Screening test include?
This test measures neutrophil oxidative burst using DHR flow cytometry and NBT reduction to evaluate for Chronic Granulomatous Disease.
How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses validated DHR and NBT assays under strict quality control to accurately assess neutrophil function.
Who should take this test?
Patients with recurrent infections, poor wound healing, or a family history of CGD may be advised to undergo this screening.
What sample type is required?
An EDTA anticoagulated blood sample is required for accurate assessment of neutrophil oxidative function.
Why is CGD screening important?
Early detection of CGD helps guide immunological evaluation, preventive care, and tailored treatment strategies to reduce infection risk.
How reliable are results from Metropolis Healthcare?
Metropolis Healthcare follows validated protocols, stringent quality control, and expert interpretation to ensure accurate and reproducible results.
Is any preparation needed before the test?
No fasting is required; patients should follow any instructions from their physician regarding sample collection.
How soon are results available?
Turnaround time may vary, but Metropolis Healthcare typically provides timely reports to support clinical evaluation and management of immune disorders.